Literature DB >> 7795769

Results of 12 nationwide epidemiological incidence surveys of Kawasaki disease in Japan.

H Yanagawa1, M Yashiro, Y Nakamura, T Kawasaki, H Kato.   

Abstract

OBJECTIVE: To describe the long-term trend of incidence and other epidemiological pictures of Kawasaki disease in Japan, by using the results of 12 nationwide epidemiological surveys on Kawasaki disease that have been conducted throughout Japan (ie, surveys that have encompassed the pediatric departments of hospitals with more than 100 beds) every 2 years since 1970.
RESULTS: At the end of December 1992, the total number of patients with this disease was 116,848 (males, 67,815; females, 49,033; male-female ratio, 1.38). The number of cases increased year by year, with three outbreaks in 1979, 1982, and 1986. There have been no cyclical changes since 1986. The incidence was higher in males and in those children who were 1 year of age or younger. The fatality rate decreased from 1% in 1974 to 0.04% in 1992.
CONCLUSIONS: The patterns of descriptive epidemiology, such as seasonality and cyclical changes in incidence, supported the theory of an infectious agent as the causal agent. However, the incidence data since 1986 provide less support for an infectious theory.

Entities:  

Mesh:

Year:  1995        PMID: 7795769     DOI: 10.1001/archpedi.1995.02170200069011

Source DB:  PubMed          Journal:  Arch Pediatr Adolesc Med        ISSN: 1072-4710


  25 in total

1.  Recognition and management of Kawasaki disease.

Authors:  R K Han; B Sinclair; A Newman; E D Silverman; G W Taylor; P Walsh; B W McCrindle
Journal:  CMAJ       Date:  2000-03-21       Impact factor: 8.262

2.  Modelling seasonal variations in the age and incidence of Kawasaki disease to explore possible infectious aetiologies.

Authors:  Virginia E Pitzer; David Burgner; Cécile Viboud; Lone Simonsen; Viggo Andreasen; Claudia A Steiner; Marc Lipsitch
Journal:  Proc Biol Sci       Date:  2012-03-07       Impact factor: 5.349

Review 3.  Recent Advances in Kawasaki Disease - Proceedings of the 3rd Kawasaki Disease Summit, Chandigarh, 2014.

Authors:  Surjit Singh; Dhrubajyoti Sharma; Sagar Bhattad; Saji Phillip
Journal:  Indian J Pediatr       Date:  2015-08-30       Impact factor: 1.967

4.  Reevaluation of the efficacy of intravenous gammaglobulin in the prevention and treatment of coronary artery lesion in Kawasaki disease.

Authors:  Lijun Qin; Mweri Tobbi Saumu; Hongwei Wang; Hong Shi; Xiufen Hu; Peixuan Cheng
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2005

5.  Cardiac sequelae of Kawasaki disease among recurrent cases.

Authors:  Y Nakamura; H Yanagawa; T Ojima; T Kawasaki; H Kato
Journal:  Arch Dis Child       Date:  1998-02       Impact factor: 3.791

Review 6.  Treatment Options for Resistant Kawasaki Disease.

Authors:  Linny Kimly Phuong; Nigel Curtis; Peter Gowdie; Jonathan Akikusa; David Burgner
Journal:  Paediatr Drugs       Date:  2018-02       Impact factor: 3.022

7.  Clinical features of recurrent Kawasaki disease and its risk factors.

Authors:  Hai-ming Yang; Zhong-Dong Du; Pei-pei Fu
Journal:  Eur J Pediatr       Date:  2013-07-26       Impact factor: 3.183

Review 8.  Kawasaki disease. The mystery continues.

Authors:  D J Bradley; M P Glodé
Journal:  West J Med       Date:  1998-01

9.  An old autopsy report sheds light on a "new" disease: infantile polyarteritis nodosa and kawasaki disease.

Authors:  Howard I Kushner; Carlos R Abramowsky
Journal:  Pediatr Cardiol       Date:  2010-01-07       Impact factor: 1.655

10.  Infliximab treatment in refractory Kawasaki syndrome.

Authors:  Meenakshi Girish; Girish Subramaniam
Journal:  Indian J Pediatr       Date:  2008-06-08       Impact factor: 1.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.